Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 23Observational 3

Sponsor

Cancer Type

Gastrointestinal 44Breast 30Thoracic 27Gynecologic 10Head & Neck 9Lymphoid 7Genitourinary 7Sarcoma 6Other hematologic neoplasm 6Dermatologic 4CNS 4Tumor-Agnostic 3Plasma cell 3Other solid neoplasm 2NET 2Myeloid 2Endocrine 2Other 1Classical hematology 1

Conditions

Neoplasms 2Neoplasm, Residual 1

Interventions

Surveys and Questionnaires 48Blood Specimen Collection 22Interviews as Topic 14Data Collection 11Magnetic Resonance Spectroscopy 6Hematologic Tests 6Specimen Handling 5Restraint, Physical 5Radiotherapy 5Palliative Care 4Observation 4Mental Status and Dementia Tests 4Watchful Waiting 3Registries 3Quality of Life 3Phlebotomy 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Lapatinib 3Immunotherapy 3Immune Checkpoint Inhibitors 3Health Records, Personal 3Focus Groups 3Drug Therapy 3Bevacizumab 3Absorptiometry, Photon 3veliparib 2talazoparib 2rucaparib 2pamiparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Drug Therapy × Tumor-Agnostic × Clear all
NCT06717178 2025-04-02

Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China

RenJi Hospital

Recruiting
322 enrolled
Tumor-Agnostic

Neoplasms

NCT05442177 2022-07-01

Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity

Taichung Tzu Chi Hospital

Completed
35 enrolled
Tumor-Agnostic

Neoplasms

NCT03491033 2018-04-10

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

Yonsei University

Completed
250 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡